Classic Intrathecal Therapy in Oncology

This publication has 11 references indexed in Scilit:

• CAR-T cell therapy for cancer: current challenges and future directions
  Signal Transduction and Targeted Therapy, 2025
• Assessing efficacy of intrathecal chemotherapy in patients with leptomeningeal metastases: A systematic review and meta-analysis.
  Journal of Clinical Oncology, 2025
• Intrathecal administration of PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from breast cancer: a case report
  Frontiers in Immunology, 2025
• A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors
  Frontiers in Pharmacology, 2025
• IMUN-03 IT-IO: INTRATHECAL ADMINISTRATION OF NIVOLUMAB AND IPILIMUMAB IN COMBINATION WITH SYSTEMIC COMBINATION OF NIVOLUMAB AND IPILIMUMAB IN PATIENTS WITH NSCLC OR MELANOMA AND NEWLY DIAGNOSED LEPTOMENINGEAL METASTASIS, A MULTICENTRIC PHASE I STUDY - PRELIMINARY DATA
  Neuro-Oncology Advances, 2024
• Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  ESMO Open, 2023
• A systematic review and meta-analysis of intrathecal versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
  Journal of Clinical Oncology, 2023
• Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer
  Cancers, 2023
• Advancements in drug delivery methods for the treatment of brain disease
  Frontiers in Veterinary Science, 2022
• Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy
  British Journal of Haematology, 2016